SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
Novel Compound May Lessen Heart Attack Damage
February 7, 2008
 · 
1 min read
Drug Development
Sorafenib Slows Growth of Some Leukemias
February 4, 2008
 · 
1 min read
Drug Development
Allergic Disease Linked To Irritable Bowel Syndrome, Rush University Medical Center Study
January 31, 2008
 · 
1 min read
Drug Development
Kidney Cancer Drug Attacks A Major Type Of Acute Myeloid Leukemia
January 30, 2008
 · 
1 min read
Drug Development
New Vaccine Against Deadliest Strain Of Avian Flu Successful In Mice
January 30, 2008
 · 
1 min read
Drug Development
Coffee Bad For Diabetics, Study Suggests
January 28, 2008
 · 
1 min read
Drug Development
New Alzheimer’s Treatment Completes First Phase Of Testing
January 28, 2008
 · 
1 min read
Drug Development
Early Promising Results In Malaria Vaccine Trial
January 23, 2008
 · 
1 min read
Drug Development
Discovery Opens Door To “Personalized” Asthma Therapy
January 21, 2008
 · 
1 min read
Drug Development
Study Probes Why US Blacks Wary Of Medical Trials
January 16, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
July 15, 2026
 · 
10 min read
Press Releases
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing
July 15, 2026
 · 
6 min read
Press Releases
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
July 15, 2026
 · 
7 min read
Press Releases
ImmunoBrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer’s Disease
July 14, 2026
 · 
5 min read
Press Releases
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
July 14, 2026
 · 
1 min read
Press Releases
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
July 14, 2026
 · 
5 min read
Press Releases
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
July 14, 2026
 · 
7 min read
Press Releases
Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026
July 14, 2026
 · 
6 min read
Press Releases
Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
July 14, 2026
 · 
3 min read
Press Releases
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
 · 
8 min read
Press Releases
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
July 13, 2026
 · 
9 min read
Press Releases
Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
July 13, 2026
 · 
4 min read
Press Releases
Ollin Biosciences Announces Upcoming Presentations of OLN324 Data in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at the American Society of Retina Specialists (ASRS) 44th Annual Scientific Meeting
July 13, 2026
 · 
2 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
 · 
5 min read
Press Releases
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
 · 
9 min read
Press Releases
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
July 13, 2026
 · 
8 min read
Press Releases
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
July 13, 2026
 · 
4 min read
Press Releases
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
July 9, 2026
 · 
7 min read
Press Releases
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
July 9, 2026
 · 
9 min read
Press Releases
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
 · 
7 min read
Load More